*001253692
*00520130801111620.0
*007ta
*008130801s2006    xx#           000 u eng d
*00901157cam a2200241 c 4500
*019  $bl
*035  $a(EXLNZ-47BIBSYS_NETWORK)990618114914702201
*035  $a(NO-LaBS)14711207(bibid)
*035  $a(NO-TrBIB)061811491
*035  $a061811491-47bibsys_network
*040  $aNO-TrBIB$bnob$ekatreg
*1001 $aBrekke, Kurt Richard$d1969-$0(NO-TrBIB)90942008$_31258800
*24510$aRegulation and pricing of pharmaceuticals :$breference pricing or price cap regulation?$cby Kurt R. Brekke, Astrid L. Grasdal, and Tor Helge Holmås
*260  $aBergen$bNorwegian School of Economics and Business Administration$c2006
*300  $a24 s.$bill.
*4901 $aDiscussion paper / Norwegian School of Economics and Business Administration, Department of Economics$vSAM 30 2006
*588  $aKatalogisert etter omslag
*7001 $aGrasdal, Astrid$d1967-$0(NO-TrBIB)59074$_26429700
*7001 $aHolmås, Tor Helge$d1960-$0(NO-TrBIB)11046724$_34265300
*7760 $tRegulation and pricing of pharmaceuticals : reference pricing or price cap regulation?$w990702815304702201
*830 0$aDiscussion paper (Norges handelshøyskole. Institutt for samfunnsøkonomi : trykt utg.)$vSAM 30 2006$w990305757884702201$_14332700
*901  $a80
*999  $aoai:nb.bibsys.no:990618114914702202$b2021-11-14T20:04:04Z$z990618114914702202
^